J&J to buy Abiomed in $16.6B deal to boost cardiovascular business
J&J's cardiovascular devices business will benefit from the $16.6 billion deal to acquire Abiomed. The deal comes at a time when J&J is spinning off its consumer health business.
Obamacare open enrollment 2023: What to know
Open enrollment for Affordable Care Act health plans begins Tuesday, and there are a slew of changes to be aware of this year when making a selection.
Biotech entrepreneur investing in a ‘new generation’ of cancer, chronic disease treatments
Graviton Chairman and co-CEO Sam Waksal details how a new drug can meet an unmet medical need treating diseases like cancer, ALS, Alzheimer’s, schizophrenia and Parkinson’s.
Pfizer says it's eyeing a $110 to $130 list price for COVID-19 vaccine in U.S.
Pfizer Inc. on Thursday revealed the possible U.S. list price it is eyeing for its adult COVID-19 vaccine doses once the shot hits the commercial market.
Florida Circle K locations to sell marijuana
Circle K gas stations in Florida will sell medical marijuana in a lease agreement with Green Thumb Industries. The sales will launch at approximately 10 stores.
Abbott CEO provides update on progress as baby formula shortage persists
Abbott Laboratories CEO Robert Ford says the company replaced leadership at its troubled Michigan facility and is building a new infant formula plant.
FDA authorizes Novavax COVID booster for adults
The Food and Drug Administration authorized the Novavax COVID-19 vaccine as a booster for use in adults on Wednesday. The company has struggled with vaccine sales.
Is Elizabeth Holmes pregnant again? Her latest court appearance sparks rumors
Elizabeth Holmes' latest court appearance sparked rumors from a star witness and even reporters that the disgraced Theranos founder is pregnant again.
Johnson & Johnson beats sales estimates on pharma strength
The company tightened its full-year adjusted profit forecast range. Sales at its medical devices unit rose to $6.78 billion on demand for contact lenses and wound-closure products.
Key witness in Elizabeth Holmes trial stands by his testimony
The prosecution's key witness in the Elizabeth Holmes trial reiterated Monday that he stands by his testimony despite doubts cast by her defense team.
Adderall shortage confirmed by FDA
The U.S. Food and Drug Administration has officially declared a nationwide shortage of ADHD drug Adderall, following weeks of warnings from manufacturers.
Elizabeth Holmes' chance for a new trial is slim despite hearing, expert says
Theranos founder Elizabeth Holmes is unlikely to be granted a new trial despite a judge agreeing to a hearing on the prospect, according to an expert.
Walgreens says staffing shortages hit prescription growth
Walgreens Boots Alliance executives said during their earnings call Thursday that pharmacy staffing shortages have created challenges for prescription growth.
Former Theranos executive Sunny Balwani denied new trial
A judge on Wednesday denied former Theranos executive Ramesh "Sunny" Balwani's request for a new trial. Balwani was convicted in June on 12 fraud charges.
FDA authorizes bivalent COVID boosters for young children
The Food and Drug Administration announced Wednesday that it was amending is emergency use authorization of bivalent COVID vaccines for use in younger kids.
Disasters like Ian pose extra risk for fragile older people
Loss of power in places affected by natural disasters are increasing concerns for the elderly and for those with limited mobility and chronic health conditions.
Adderall shortages impacting ADHD patients
Widespread shortages of ADHD drug Adderall and other alternatives across the country are causing panic for patients who rely on the medication to focus.
CVS in exclusive talks to acquire Cano Health: report
Shares of Cano Health climbed on Friday following a report the value-based primary care provider is in exclusive talks to be bought by CVS Health. The Miami-based healthcare provider went public in June 2021.
Zero-premium Medicare Advantage plans: What to know
Zero-premium Medicare Advantage plans are popular, but not all coverage is the same. Here's what shoppers should know ahead of next week's enrollment.
Hurricane Ian victims should get insurance claims in early: Deborah Hoffman
SWFL Insurance owner Deborah Hoffman discusses how Hurricane Ian is affecting Florida's insurance market on 'The Claman Countdown.'

















